DEA Extends Telehealth Flexibilities
APA’s policy team is working to update materials, but has informed members that the DEA and HHS issued a second temporary extension of COVID-19 telemedicine flexibilities for prescription of controlled medications, further extending exceptions to the existing DEA regulations through December 31, 2024.